Information:
Fel:
ID
16664
Beskrivning
An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT00684385
Länk
https://clinicaltrials.gov/show/NCT00684385
Nyckelord
Versioner (1)
- 2016-07-30 2016-07-30 -
Uppladdad den
30 juli 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non Small Cell Lung Cancer (NSCLC) DRKS00005552 NCT00684385
Eligibility Non Small Cell Lung Cancer (NSCLC) NCT00684385
- StudyEvent: Eligibility
Similar models
Eligibility Non Small Cell Lung Cancer (NSCLC) NCT00684385
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
prior chemotherapy or radiation therapy
Item
have received at least one course of standard systemic chemotherapy or radiation therapy
boolean
C0279134 (UMLS CUI [1])
C1514457 (UMLS CUI [2])
C1514457 (UMLS CUI [2])
ineligible for chemotherapy or radiotherapy
Item
are ineligible for chemotherapy or radiotherapy
boolean
C1512714 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C1512714 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C0392920 (UMLS CUI [1,2])
C1512714 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
ineligible for zd1839 trials
Item
are ineligible or not candidates for enrollment in available zd1839 trials for nsclc or squamous cell h&nc
boolean
C1512714 (UMLS CUI [1,1])
C0879396 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0879396 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
not medically suitable for chemotherapy.
Item
are, in the investigators opinion, not medically suitable for chemotherapy.
boolean
C1512714 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,2])
current eligibility for any zd1839 protocol
Item
current eligibility (i.e., meeting the inclusion and exclusion criteria except signed informed consent) for any zd1839 protocol available to the patient, or previous enrollment in a blinded zd1839 protocol
boolean
C1512693 (UMLS CUI [1,1])
C0879396 (UMLS CUI [1,2])
C0879396 (UMLS CUI [1,2])
study participation status
Item
patients from a blinded protocol may be considered for acceptance, with astrazeneca's permission, only after trial completion and unblinding of all patients.
boolean
C2348568 (UMLS CUI [1])
ID.7
Item
patients eligible for or previously enrolled in an open-label or unblinded zd1839 clinical trial may be considered for acceptance with astrazeneca's permission
boolean
C2348568 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0879396 (UMLS CUI [1,3])
C1512693 (UMLS CUI [1,2])
C0879396 (UMLS CUI [1,3])
incomplete healing from prior oncologic or other major surgery
Item
incomplete healing from prior oncologic or other major surgery
boolean
C0151692 (UMLS CUI [1])